DMED — Diagnamed Holdings Share Price
Last trade - 00:00- CA$1.61m
- CA$1.23m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 16.19 | ||
| Price to Tang. Book | 16.19 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -391.55% | ||
| Return on Equity | -155.81% | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 30th Sep | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CA$m | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
DiagnaMed Holdings Corp. is a Canada-based generative artificial intelligence healthcare company. The Company is focused on developing and commercializing CERVAI, a proprietary brain health artificial intelligence (AI) platform. CERVAI leverages generative AI that predicts and monitors brain age and provides actionable insights and tools to diagnose, prevent or improve cognitive decline for mental health and neurodegenerative disorders. The Company is developing and commercializing a suite of generative AI solutions powered by OpenAI's ChatGPT to support the healthcare market in improving patient outcomes, operational workflow and efficiency. AI Medical Chatbot is a personal medical chatbot designed to give people a way to obtain fast and personalized medical information based on a person’s unique medical condition.
Directors
- Last Annual
- September 30th, 2023
- Last Interim
- March 31st, 2024
- Incorporated
- April 16th, 2021
- Public Since
- November 8th, 2022
- Sector
- Software & IT Services
- Industry
- Technology
- Exchange
- Canadian Securities Exchange
- Shares in Issue
- 80,477,740
- Address
- Suite 2900, 550 Burrard Street, VANCOUVER, V6C 0A3
- Web
- https://www.diagnamed.com/
- Phone
- +1 7786834324
- Auditors
- CLEARHOUSE LLP
Similar to DMED
AI/ML Innovations
Canadian Securities Exchange
AlphaGen Intelligence
Canadian Securities Exchange
Ampd Ventures
Canadian Securities Exchange
Anonymous Intelligence
Canadian Securities Exchange
Apartmentlove
Canadian Securities Exchange
FAQ
As of Today at 20:15 UTC, shares in Diagnamed Holdings are trading at CA$0.03. This share price information is delayed by 15 minutes.
Shares in Diagnamed Holdings last closed at CA$0.03 and the price had moved by -57.14% over the past 365 days. In terms of relative price strength the Diagnamed Holdings share price has underperformed the Toronto Stock Exchange 300 Composite Index by -61.39% over the past year.
There is no consensus recommendation for this security.
Diagnamed Holdings does not currently pay a dividend.
Diagnamed Holdings does not currently pay a dividend.
Diagnamed Holdings does not currently pay a dividend.
To buy shares in Diagnamed Holdings you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of CA$0.03, shares in Diagnamed Holdings had a market capitalisation of CA$2.41m.
Here are the trading details for Diagnamed Holdings:
- Country of listing: Canada
- Exchange: CNX
- Ticker Symbol: DMED
Based on an overall assessment of its quality, value and momentum Diagnamed Holdings is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Diagnamed Holdings. Over the past six months, its share price has underperformed the Toronto Stock Exchange 300 Composite Index by -2.5%.
As of the last closing price of CA$0.03, shares in Diagnamed Holdings were trading -28.78% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Diagnamed Holdings PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at CA$0.03.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Diagnamed Holdings' directors